antibodi
critic
reagent
mani
fundament
biochem
method
affi
niti
chromatographi
enzymelink
immunosorb
assay
elisa
fl
ow
cytometri
western
blot
immunoprecipit
immunohistochemistri
techniqu
understand
proteom
becom
complex
demand
rise
rapidli
gener
antibodi
higher
specifi
citi
ever
therefor
surpris
investig
move
beyond
classic
method
antibodi
product
search
new
reagent
despit
longstand
effi
caci
recombin
antibodi
gener
technolog
phage
display
still
larg
tool
biotechnolog
compani
research
group
direct
interest
protein
engin
chapter
discuss
inher
limit
classic
polyclon
monoclon
antibodi
gener
highlight
attract
altern
gener
highspecifi
citi
highaffi
niti
recombin
antibodi
altern
immun
sourc
chicken
via
phage
display
rapid
expans
genom
proteom
biotechnolog
fi
eld
led
grow
demand
affi
niti
reagent
specifi
calli
recogn
protein
peptid
carbohydr
hapten
affi
niti
reagent
high
specifi
citi
routin
requir
divers
protein
drug
target
member
newli
discov
biochem
pathway
posttransl
modifi
ed
protein
protein
cleavag
product
even
small
molecul
drug
abus
toxin
individu
biomed
research
often
need
monitor
quantifi
purifi
protein
interest
via
affi
niti
chromatographi
may
commerci
avail
antibodi
reagent
allow
inde
even
situat
commerci
avail
antibodi
reagent
often
expens
poorli
character
andor
simpli
appropri
demand
applic
compound
problem
technic
diffi
culti
monoclon
antibodi
gener
untrain
research
high
cost
commerci
monoclon
antibodi
gener
program
lead
mani
research
default
solut
produc
polyclon
hyperimmun
sera
host
rabbit
net
result
research
often
settl
reagent
lack
necessari
specifi
citi
perform
applic
intend
review
outlin
limit
classic
antibodi
gener
technolog
illustr
attract
altern
use
phage
display
librari
recombin
antibodi
built
immunoglobulin
repertoir
nonmammalian
anim
particular
highlight
advantag
librari
deriv
domest
chicken
gallu
gallu
offer
rel
inexpens
technic
access
rout
highqual
monoclon
reagent
like
mani
peopl
purchas
paid
gener
costli
specifi
c
antibodi
subsequ
found
actual
polyreact
dubiou
qualiti
phage
display
immun
chicken
may
offer
attract
altern
hyperimmun
sera
rabbit
sheep
mammal
may
produc
larg
quantiti
offer
consist
monoclon
antibodi
need
regularli
replenish
recharacter
serum
antibodi
also
polyclon
frequent
polyspecifi
c
even
purifi
ed
antigen
column
render
suboptim
specifi
c
recognit
singl
compon
complex
matrix
one
illumin
studi
demonstr
use
probe
comprehens
yeast
proteom
chip
unpurifi
ed
polyclon
antibodi
prepar
could
recogn
differ
protein
monoclon
antibodi
antigen
columnpurifi
ed
polyclon
antibodi
also
recogn
multipl
protein
relat
unrel
arriv
monoclon
antibodi
technolog
major
step
forward
gener
highspecifi
citi
reagent
relianc
murin
immunoglobulin
system
frequent
lead
number
practic
diffi
culti
monoclon
antibodi
rais
basi
ineffi
cient
fusion
splenic
bcell
immort
mous
myeloma
line
follow
limit
dilut
cell
popul
targetspecifi
c
antibodi
randomli
identifi
ed
often
simpl
direct
elisa
precondit
set
determin
antibodi
identifi
ed
one
must
take
one
get
screen
process
often
desir
multipl
monoclon
antibodi
specifi
citi
differ
epitop
target
molecul
diffi
culti
sequenc
monoclon
allow
rapid
identifi
cation
uniqu
clone
earli
screen
process
human
rodent
rel
close
relat
phylogenet
mani
protein
interest
highli
conserv
among
mammal
frequent
lead
thymic
toler
restrict
antibodi
respons
immun
immun
respons
human
protein
rais
mice
larg
region
sequenc
similar
murin
human
protein
may
lead
restrict
number
immunogen
epitop
gener
antibodi
crossreact
orthologu
multipl
speci
mammal
particularli
tricki
common
epitop
among
mammal
one
unlik
provok
strong
immunoglobulin
respons
mous
toler
issu
becom
even
harder
circumv
protein
interest
mous
rat
creat
knockout
mice
endogen
copi
gene
target
protein
disabl
often
break
toler
highli
labori
timeconsum
process
laboratori
resourc
undertak
factor
hinder
gener
highqual
antibodi
reagent
therebi
limit
one
experiment
option
develop
antibodi
purifi
track
novel
protein
bypass
limit
polyclon
monoclon
antibodi
gener
sever
group
turn
vitro
display
technolog
phage
display
ribosom
display
yeast
display
librari
gener
recombin
antibodi
recent
technolog
yeast
ribosom
display
becom
highli
establish
phage
display
current
robust
well
character
reliabl
method
antibodi
deriv
technolog
clone
microbi
host
therefor
monoclon
start
product
easili
scale
critic
select
screen
effort
direct
toward
specifi
c
epitop
speci
crossreact
away
polyspecifi
c
bind
phage
display
allow
research
singl
tube
would
unfathom
tradit
hybridoma
work
interrog
librari
million
ten
billion
antibodi
basi
bind
specifi
calli
target
interest
possibl
due
ingeni
concept
genotypetophenotyp
linkag
exemplifi
ed
phage
display
phage
display
origin
describ
rapid
method
clone
gene
fragment
encod
specifi
c
protein
clone
gene
fragment
genom
fi
lament
e
coli
bacteriophag
smith
et
al
abl
gener
librari
gene
fusion
key
phage
coat
protein
transform
e
coli
viral
replic
system
packag
genom
therefor
clone
gene
highli
stabl
complex
carri
gene
product
tip
phage
particl
fusion
protein
subsequ
select
express
virion
immobil
antibodi
specifi
citi
known
protein
clone
phage
genom
abl
show
enrich
gene
product
set
experi
show
genotypetophenotyp
linkag
could
achiev
therebi
defi
ned
basi
display
technolog
develop
sinc
subsequ
develop
method
effect
clone
antibodi
vgene
sequenc
via
pcr
allow
captur
antibodi
sequenc
recombin
form
remov
need
immort
bcell
via
hybridoma
fusion
requir
tradit
monoclon
antibodi
gener
discoveri
combin
phage
display
process
make
effi
cient
method
isol
antibodi
correspond
gene
sequenc
simultan
antibodi
phage
display
process
librari
divers
vgene
sequenc
clone
appropri
express
vector
e
coli
creat
infram
fusion
protein
favor
recent
describ
librari
truncat
form
phage
display
protein
librari
origin
perform
use
phage
vector
ie
built
upon
phage
genom
due
practic
diffi
culti
handl
librari
recent
phage
method
mostli
use
socal
phagemid
express
vector
case
dna
backbon
stabl
small
plasmid
puc
gene
plu
phage
packag
origin
phagederiv
dna
sequenc
phagemid
librari
easili
handl
stabl
phage
librari
plasmid
incap
caus
phage
product
librari
therefor
simpli
clone
expand
control
phage
librari
infect
helper
phage
base
grow
cultur
e
coli
harbor
phagemid
librari
phage
propag
machineri
provid
due
mutat
introduc
origin
replic
helper
phage
genom
preferenti
packag
phagemid
dna
fusion
occur
phage
replic
phage
product
therebi
induc
genotypetophenotyp
linkag
creat
express
phage
particl
interrog
presenc
use
protein
sequenc
via
target
bind
select
step
may
perform
simpli
immobil
target
protein
exampl
proteinbind
plastic
surfac
elisa
plate
ad
phage
allow
bind
occur
via
fusion
protein
nonbind
phage
remov
wash
immobil
surfac
remain
bound
phage
elut
elut
phage
reinfect
back
fresh
cultur
e
coli
retriev
select
gene
sequenc
process
perfect
howev
two
four
round
selectionreexpressionselect
normal
perform
iter
remov
unwant
clone
enrich
bind
popul
background
librari
nonetheless
process
spectacularli
power
massiv
enrich
specifi
c
antibodi
singl
select
round
furthermor
use
multipl
form
target
antigen
sequenti
select
round
inclus
competitor
protein
drive
select
pool
toward
highli
specifi
c
set
epitop
much
evolut
progress
phage
display
technolog
driven
remark
discoveri
method
use
mine
larg
librari
combinatori
human
antibodi
divers
theoret
remov
need
anim
antibodi
product
random
recombin
v
h
v
l
sequenc
human
lymphocyt
cdna
use
degener
oligonucleotid
creat
divers
dna
sequenc
loop
associ
target
bind
sever
group
creat
larg
librari
antibodi
gene
sequenc
phage
display
librari
analog
antibodi
repertoir
anim
select
result
identifi
cation
antibodi
fragment
exhibit
high
specifi
citi
occasion
high
affi
niti
target
protein
sever
major
studi
proven
appropri
applic
technolog
specifi
c
antibodi
rais
protein
peptid
hapten
even
carbohydr
exemplari
studi
antibodi
rais
equival
affi
niti
associ
strong
humor
immun
respons
addit
antibodi
suboptim
affi
niti
provid
use
start
molecul
construct
mutagen
librari
screen
affi
niti
matur
variant
addit
affi
niti
matur
process
phage
display
also
provid
use
tool
product
ultrahuman
antibodi
nonhuman
sourc
wide
accept
intrins
diffi
culti
associ
human
nonhuman
antibodi
use
cdr
graft
frequent
graft
antibodi
suffer
immunogen
associ
high
nongermlin
amino
acid
content
propens
vdomain
destabil
often
downstream
express
formul
issu
recent
studi
ultrahuman
antibodi
three
nonhuman
sourc
gener
via
singlestep
complementaritydetermin
region
cdr
germlin
process
term
augment
binari
substitut
ab
process
util
phage
display
select
germlin
target
combinatori
librari
result
identifi
cation
cdr
residu
amen
human
germlin
without
compromis
specifi
citi
affi
niti
degre
complex
incorpor
librari
random
substitut
residu
tandem
germlin
process
simpl
singl
pass
process
gener
signifi
cantli
lower
nongermlin
sequenc
content
cdr
graft
nonhuman
host
render
virtual
indistinguish
fulli
human
antibodi
process
open
new
possibl
affi
niti
matur
human
antibodi
altern
sourc
chicken
recombin
antibodi
typic
display
express
fragment
form
simplest
commonli
use
fragment
singlechain
fragment
variabl
scfv
fl
exibl
peptid
sequenc
link
vregion
antibodi
cterminu
one
domain
nterminu
therebi
combin
vdomain
singl
polypeptid
scfv
may
assembl
v
l
v
h
v
h
v
l
orient
v
h
v
l
heavili
use
format
histor
fl
exibl
linker
help
make
scfv
simpl
express
must
suffici
long
fl
exibl
allow
effect
associ
vregion
form
function
antigencombin
site
long
true
classic
hydrophob
pair
vregion
stabil
structur
far
common
linker
base
glycineserin
repeat
structur
gggg
second
commonli
use
recombin
antibodi
format
fab
fragment
antigen
bind
molecul
structur
complet
bind
arm
antibodi
compris
full
immunoglobulin
light
chain
express
conjunct
v
h
c
h
region
heavi
chain
fab
oblig
form
predominantli
monomer
monoval
fragment
natur
recombin
antibodi
fragment
shown
presenc
constant
region
often
help
stabil
antibodi
variabl
region
fab
format
less
commonli
use
two
main
recombin
antibodi
format
howev
dual
polypeptid
structur
gener
diffi
cult
express
display
e
coli
scfv
recent
engin
scfab
platform
howev
attempt
address
limit
associ
scfab
express
much
underus
phage
display
may
due
experi
earli
librari
deriv
synthet
human
antibodi
divers
donat
academ
laboratori
specifi
calli
invest
antibodi
engin
unfortun
foray
display
technolog
often
left
investig
somewhat
disappoint
mani
peopl
accept
viewpoint
recombin
antibodi
technolog
expert
librari
yield
use
highaffi
niti
antibodi
form
antigen
gener
mostli
highli
skill
fi
eld
inde
true
averag
antibodi
gener
librari
often
disappointingli
low
affi
niti
use
highsensit
antibodi
immun
sourc
human
recombin
antibodi
librari
sourc
requir
technic
challeng
vitro
molecular
evolut
perform
demand
real
world
function
requir
mani
reagent
antibodi
molecular
evolut
far
trivial
perform
usual
beyond
scope
interest
level
averag
research
reason
littl
wonder
peopl
either
ignor
worst
disparag
phage
display
technolog
nevertheless
phage
display
rel
simpl
technolog
use
employ
har
natur
repertoir
antibodi
immun
anim
offer
rapid
path
highli
specifi
c
highaffi
niti
antibodi
problemat
antigen
success
antibodi
librari
contain
member
often
domain
biotechnolog
compani
typic
immun
librari
rang
easili
assembl
singl
investig
immun
rabbit
sheep
rais
signifi
cant
serum
immunoglobulin
titer
common
endpoint
experi
exsanguin
anim
harvest
serum
howev
harvest
bcell
rich
lymphoid
tissu
anim
spleen
bone
marrow
allow
isol
total
rna
subsequ
gener
cdna
simpl
method
mani
biomed
research
familiar
commerci
kit
avail
simplifi
step
process
immunoglobulin
gene
sequenc
mani
anim
known
cdna
immun
tissu
subsequ
use
rtpcr
amplifi
cation
clone
anim
variabl
region
sequenc
repertoir
clone
variabl
region
sequenc
assembl
display
librari
format
scfv
chimer
fab
use
human
c
h
c
region
target
immun
librari
therebi
offer
potenti
huge
advantag
monoclon
antibodi
librari
variant
may
built
allow
effect
sampl
much
broader
rang
antibodi
hundr
occasion
thousand
clone
usual
examin
monoclon
antibodi
screen
result
librari
interrog
specifi
c
bind
protein
via
phage
display
retriev
antibodi
fragment
express
simpli
bacteria
process
use
success
har
antibodi
repertoir
larg
number
immun
host
speci
includ
mice
rabbit
sheep
camelid
shark
greater
interest
us
howev
exploit
approach
harvest
novel
immunoglobulin
repertoir
domest
chicken
gallu
gallu
simpl
use
mice
rabbit
also
highli
phylogenet
distant
mammal
avian
circumv
mani
common
problem
encount
mammalian
immun
describ
fulli
domest
small
anim
chicken
attract
host
immun
highli
access
afford
easili
hous
gener
anim
hous
importantli
howev
amino
acid
homolog
mammalian
avian
orthologu
given
protein
typic
lower
mammal
commonli
use
antibodi
gener
inde
mammalian
protein
may
even
exist
avian
immunoglobulin
respons
chicken
highli
conserv
mammalian
protein
reliabl
robust
gener
exhibit
high
avid
potenti
target
broad
spectrum
epitop
protein
immunogen
chicken
therefor
potenti
major
advantag
common
immun
host
produc
highaffi
niti
crossreact
antibodi
respons
target
epitop
conserv
across
multipl
orthologu
mammalian
protein
lead
signifi
cant
save
time
resourc
singl
broadli
applic
clone
reagent
identifi
ed
use
gener
singl
affi
niti
column
captur
target
protein
multipl
speci
chicken
immunoglobulin
also
shown
benefi
cial
biophys
properti
exhibit
high
stabil
chang
ph
temperatur
provid
function
coat
latex
microspher
demonstr
function
direct
coval
coupl
dextran
layer
detect
serum
protein
surfac
plasmon
reson
furthermor
chicken
small
anim
littl
protein
immunogen
requir
rais
strong
immunoglobulin
respons
approxim
purifi
ed
protein
suffi
cient
carri
full
immun
regim
observ
led
regular
use
chicken
immun
host
product
polyclon
antibodi
term
igi
egg
yolk
antibodi
research
commerci
set
lay
hen
export
signifi
cant
quantiti
polyclon
igi
egg
mg
igi
per
yolk
process
analog
mammalian
placent
igg
transfer
allow
direct
screen
antibodi
respons
without
need
serum
sampl
strong
immun
respons
rais
larg
quantiti
polyclon
antibodi
easili
prepar
yolk
polyclon
antibodi
success
appli
research
immunochemistri
diagnost
affi
niti
column
purifi
cation
inde
immunodeplet
resin
base
chicken
igi
use
remov
high
abund
protein
serum
commerci
avail
sigmaaldrich
seppro
spin
column
unfortun
polyclon
igi
still
suffer
issu
illdefi
ned
specifi
citi
polyclon
antibodi
prepar
addit
sever
studi
describ
success
chicken
hybridoma
monoclon
antibodi
gener
antigen
human
peptid
sporozoit
protein
prion
protein
low
antibodi
express
instabl
associ
chicken
myeloma
cell
line
led
underus
speci
sourc
monoclon
antibodi
today
howev
progress
chicken
antibodi
phage
display
circumv
problem
made
recombin
chicken
antibodi
reagent
readili
access
describ
chicken
immunoglobulin
repertoir
almost
ideal
suit
antibodi
phage
display
chicken
gener
immunoglobulin
repertoir
singl
set
v
h
v
l
germ
line
sequenc
major
posit
framework
region
maintain
germlin
divers
vregion
creat
vdj
recombin
somat
hypermut
addit
infl
uenc
gene
convers
multipl
upstream
pseudogen
recombin
function
sequenc
germlin
vgene
system
mean
entir
chicken
antibodi
repertoir
captur
use
four
pcr
primer
make
chicken
librari
highli
repres
induc
immunoglobulin
respons
direct
contrast
immun
host
mice
divers
germlin
vgene
sequenc
therefor
requir
complex
mix
pcr
primer
addit
two
vgene
germlin
sequenc
found
chicken
highli
homolog
human
v
v
h
germlin
famili
associ
creat
vdomain
high
stabil
solubl
inde
chicken
scfv
stabl
crude
bacteri
cultur
supernat
month
room
temperatur
initi
work
davi
et
al
show
simpl
recombin
chicken
antibodi
librari
could
display
phage
small
librari
nonimmun
deriv
bursa
cell
singl
young
chicken
group
abl
select
targetspecifi
c
scfv
sequenc
recogn
lysozym
serum
albumin
thyroglobulin
potenti
chicken
recombin
antibodi
highlight
studi
use
scfv
librari
deriv
spleen
immun
chicken
success
gener
highli
specifi
c
scfv
antibodi
target
mous
rat
serum
albumin
toler
issu
limit
abil
gener
murin
monoclon
antibodi
addit
indepth
analysi
avian
immunoglobulin
v
h
repertoir
demonstr
repertoir
featur
fulli
replic
result
targetselect
phage
display
repertoir
major
studi
subsequ
demonstr
chicken
could
use
sourc
scfv
chimer
fab
antibodi
specifi
citi
hapten
molecul
howev
none
earli
studi
character
antibodi
affi
niti
function
practic
reagent
recent
studi
shown
scfv
antibodi
deriv
immun
chicken
highli
effect
reagent
divers
set
diagnost
elisa
infecti
bursal
diseas
viru
diagnosi
prion
diseas
immunodetect
hapten
shellfi
sh
toxin
immunostain
sarsinfect
cell
biosens
cardiac
biomark
measur
apob
protein
mous
human
sera
raat
et
al
also
illustr
antiidiotyp
scfv
immun
chicken
scfv
librari
consider
higher
sensit
deriv
human
antibodi
librari
studi
gener
highli
select
scfv
toward
prp
protein
highli
conserv
mammal
demonstr
advantag
chicken
immun
model
isol
scfv
shown
react
murin
ovin
bovin
orthologu
protein
clone
chicken
antibodi
via
phage
display
also
allow
precis
dissect
specifi
citi
affi
niti
chicken
immunoglobulin
respons
highthroughput
affi
niti
measur
panel
chicken
scfv
infl
ammatori
biomark
creactiv
protein
identifi
ed
clone
preferenti
recogn
multimer
monomer
form
protein
studi
clone
affi
niti
high
pm
gener
immun
phage
display
librari
total
clone
addit
chicken
antiprp
scfv
report
affi
niti
pm
make
among
highest
affi
niti
scfv
report
date
may
particular
practic
interest
mani
research
chicken
serv
host
simultan
immun
multipl
protein
interest
mani
eight
protein
use
success
singl
immun
scheme
target
protein
interest
mix
singl
adjuv
prepar
immun
anim
receiv
multiplex
protein
simultan
spleen
bone
marrow
tissu
immun
anim
use
gener
rel
small
phage
display
librari
specifi
c
antibodi
deriv
via
select
librari
separ
individu
protein
origin
use
immun
immun
chicken
appear
react
protein
fulli
independ
phage
display
librari
gener
individu
scfv
antibodi
clone
fulli
specifi
c
western
blot
elisa
show
reactiv
coimmunogen
approach
major
benefi
ts
practic
ethic
allow
use
singl
librari
deriv
highaffi
niti
antibodi
group
protein
interest
multiimmun
method
also
simultan
minim
anim
use
rais
likelihood
success
gener
immedi
use
reagent
multitarget
immun
regim
design
one
two
object
mind
firstli
simplest
scenario
combin
multipl
unrel
protein
lead
unrel
bcell
respons
immun
deriv
antibodi
greatest
specifi
citi
multitarget
immun
kind
import
ensur
protein
immunogen
highli
purifi
ed
close
relat
protein
coimmun
singl
anim
secondli
deriv
antibodi
crossreact
orthologu
conserv
protein
multipl
speci
like
benefi
cial
necessarili
essenti
includ
orthologu
mix
immunogen
given
anim
iter
select
round
chang
orthologu
time
use
bia
toward
isol
crossreact
antibodi
gener
select
chicken
recombin
antibodi
extrem
reliabl
use
method
describ
detail
accompani
chapter
subsequ
identifi
cation
sequenc
antibodi
display
characterist
desir
also
perform
simpli
gener
scfv
isol
immun
chicken
librari
exhibit
high
affi
niti
assay
via
direct
elisa
use
crude
periplasm
extract
protein
express
e
coli
clone
level
downstream
analysi
carri
posit
hit
identifi
ed
bind
elisa
depend
end
user
requir
specifi
c
bind
function
may
suffi
ce
scfv
use
simpli
reagent
antibodi
vitro
analysi
sampl
via
elisa
western
blot
antibodi
use
affi
niti
chromatographi
antibodi
fragment
must
purifi
ed
test
function
coupl
solid
matrix
specifi
citi
purifi
cation
studi
perform
use
antibodi
fragment
affi
niti
chromatographi
sever
potenti
approach
describ
antibodi
bind
site
fulli
solventexpos
activ
antibodi
fragment
must
direct
captur
onto
solid
matrix
even
fulllength
igg
nonspecifi
c
adsorpt
coval
coupl
onto
solid
support
lead
denatur
reduc
negat
antigenbind
function
antibodi
fragment
may
slightli
prone
chemic
physic
denatur
fulllength
immunoglobulin
scfv
fab
use
success
affi
niti
chromatographi
creation
spr
sens
surfac
go
serial
round
bind
regener
mcelhinney
et
al
creat
simpl
scfvbase
affi
niti
column
concentr
cleanup
microcystin
toxin
environment
sampl
transient
coupl
histag
scfv
dispos
nickel
chelat
column
scfv
therebi
coupl
direct
maxim
function
antibodi
content
column
analyt
purifi
cation
coelut
scfv
quantifi
cation
reversephas
hplc
howev
method
use
limit
number
condit
interact
histag
nickel
noncoval
ph
depend
possibl
use
low
affi
niti
express
tag
includ
e
coli
maltos
bind
protein
glutathion
transferas
success
protein
purifi
cation
see
also
chapter
discuss
protein
tag
high
affi
niti
highli
stabl
linkag
via
affi
niti
tag
may
also
achiev
sitespecifi
c
biotinyl
antibodi
fragment
immobil
onto
matrix
passiv
coval
coat
avidin
bacteri
express
vector
avail
introduc
biotin
specifi
c
peptid
tag
avitag
produc
termini
recombin
protein
similar
method
proven
effi
cient
product
fab
specifi
calli
biotinyl
vivo
bacteri
express
via
ctermin
fusion
fab
e
coli
acetylcoa
carboxylas
importantli
biotinyl
fab
success
use
purifi
recombin
tnfalpha
bacteri
lysat
via
streptavidin
column
peptid
tag
method
also
use
success
label
fab
scfv
antibodi
orient
immobil
use
captur
antibodi
clinic
diagnost
elisa
studi
suggest
biotinstreptavidin
coupl
simpl
rapid
method
stabl
direct
captur
recombin
antibodi
fragment
coval
coupl
recombin
antibodi
fragment
via
reactiv
lysin
side
chain
like
disrupt
function
altern
coval
coupl
method
identifi
ed
simplest
exampl
disulfi
de
bond
link
two
constant
region
fab
reduc
use
mild
agent
expos
cystein
thiol
thiol
group
use
coval
coupl
fragment
thiolactiv
surfac
eleg
version
approach
express
antibodi
fragment
ctermin
cystein
group
gentli
appli
chemistri
preferenti
reduc
expos
disulphid
group
expos
termin
thiol
effi
cient
reactiv
group
coval
attach
also
possibl
express
scfv
fuse
constant
region
human
igg
light
chain
anoth
sourc
usabl
cystein
residu
extern
vregion
whether
attach
method
appropri
given
affi
niti
purifi
cation
applic
may
decid
upon
individu
investig
case
stabl
linkag
achiev
column
reus
prudent
investig
examin
multipl
clone
stabil
repeat
cycl
elut
regener
chicken
scfv
built
upon
natur
stabl
framework
stabil
differ
clone
taken
grant
case
stabil
remain
issu
appropri
chicken
vregion
clone
fcfusion
igg
express
vector
produc
fulllength
antibodi
mammalian
yeast
even
plant
cultur
system
conclus
chapter
demonstr
phage
display
power
technolog
use
gener
highli
specifi
c
reagent
immun
sourc
attract
altern
classic
antibodi
gener
technolog
employ
mani
fi
eld
reliabl
antibodi
antibodi
fragment
gener
